NCT00582361

Brief Summary

This project is designed as a prospective, randomized, comparative study evaluating the use of a negative pressure vacuum device in treating traumatic wounds sustained associated with an open fracture.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2001

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2001

Completed
6.6 years until next milestone

First Submitted

Initial submission to the registry

December 20, 2007

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 28, 2007

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2010

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

January 24, 2013

Completed
Last Updated

August 14, 2013

Status Verified

May 1, 2012

Enrollment Period

7.3 years

First QC Date

December 20, 2007

Results QC Date

July 27, 2011

Last Update Submit

August 5, 2013

Conditions

Keywords

Open FracturesVacuum Assisted Closure (VAC) deviceIrrigation and Debridement

Outcome Measures

Primary Outcomes (2)

  • Healing of Orthopaedic Trauma Open Fractures

    Healing of the open wound following orthopaedic trauma open fracture surgery was measured in days. (The wound has healed adequately to permit closure)

    from surgery to wound closure

  • Infections

    Number of acute, delayed and deep wound infections.

    Up to 12 months

Study Arms (2)

1, A

ACTIVE COMPARATOR

Group A patients will have a standard dressing applied following initial treatment of their open fracture.

Procedure: Standard Wound Dressing

2, B

EXPERIMENTAL

Group B patients will have a Vacuum Assisted Closure (VAC) device applied following initial treatment of their open fracture.

Device: VAC

Interventions

Group A patients will have a standard dressing applied following initial treatment of their open fracture. They will return to the operating room approximately 48 hours following the initial trauma, and approximately every 48 hours thereafter, for irrigation and debridement and concomitant wound cultures (qualitative and quantitative) until such time as the wound is judged by the surgeon to be ready for either delayed primary closure or flap/skin graft coverage.

1, A
VACDEVICE

Group B patients will have a Vacuum Assisted Closure (VAC) device applied following initial treatment of their open fracture. They will return to the operating room approximately 48 hours following the initial trauma, and approximately every 48 hours thereafter, for irrigation and debridement and concomitant wound cultures (qualitative and quantitative) until such time as the wound is judged by the surgeon to be ready for either delayed primary closure or flap/skin graft coverage.

Also known as: Vacuum Assisted Closure (VAC)
2, B

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient who has sustained an open fracture that requires surgical irrigation and debridement.
  • No gross clinical evidence of infection.

You may not qualify if:

  • A grossly infected open wound. Infection will be defined by clinical signs and symptoms of infection that include increasing drainage, increasing pain, purulent drainage, and increasing erythema. Any wounds that are thought to be infected will be cultured to confirm the diagnosis.
  • A surgical incision that can not be covered with VAC sponges and a water impermeable sheet (such as Ioban or Tegaderm) to achieve a closed vacuum environment over the wound.
  • Wounds associated with the surgical incision that are intentionally left open to heal with either a delayed primary closure or secondary granulation
  • Abnormal coagulation leading to an expanding hematoma that will require surgical debridement.
  • Pregnant women.
  • Inability or unwillingness to comply with protocol.
  • Patients or family members who are unable or unwilling to sign study informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Alabama at Birmingham, Orthopaedic Trauma

Birmingham, Alabama, 35294, United States

Location

Related Publications (2)

  • Parrett BM, Matros E, Pribaz JJ, Orgill DP. Lower extremity trauma: trends in the management of soft-tissue reconstruction of open tibia-fibula fractures. Plast Reconstr Surg. 2006 Apr;117(4):1315-22; discussion 1323-4. doi: 10.1097/01.prs.0000204959.18136.36.

    PMID: 16582806BACKGROUND
  • Steiert AE, Partenheimer A, Schreiber T, Muehlberger T, Krettek C, Lahoda LU, Vogt PM. [The V.A.C. system (vacuum assisted closure) as bridging between primary osteosynthesis in conjunction with functional reconstructed of soft tissue--open fractures type 2 and type 3]. Zentralbl Chir. 2004 May;129 Suppl 1:S98-100. doi: 10.1055/s-2004-822658. German.

    PMID: 15168301BACKGROUND

MeSH Terms

Conditions

Fractures, Open

Interventions

Negative-Pressure Wound Therapy

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and Injuries

Intervention Hierarchy (Ancestors)

DrainageTherapeuticsSurgical Procedures, OperativeWound Closure Techniques

Limitations and Caveats

None Noted.

Results Point of Contact

Title
Research Nurse Coordinator
Organization
UAB

Study Officials

  • Rena L Stewart, MD

    The University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2007

First Posted

December 28, 2007

Study Start

June 1, 2001

Primary Completion

September 1, 2008

Study Completion

January 1, 2010

Last Updated

August 14, 2013

Results First Posted

January 24, 2013

Record last verified: 2012-05

Locations